Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)

Similar documents
SUPPLEMENTAL MATERIAL

2013 AAIC WW-ADNI Meeting, Boston K-ADNI Update

Department of Psychology, Sungkyunkwan University, Seoul, Korea

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

Neuropsychological Evaluation of

Table 2B: Summary of Select Screening and Initial Assessment Tools for Vascular Cognitive Impairment in Stroke Patients (Updated 2014)

UDS version 3 Summary of major changes to UDS form packets

NEUROPSYCHOMETRIC TESTS

Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients

CRITICALLY APPRAISED PAPER (CAP)

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013

Montreal Cognitive Assessment 5-Minute Protocol Is a Brief, Valid, Reliable, and Feasible Cognitive Screen for Telephone Administration

I IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136

Trail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6

Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators

International Forum on HIV and Rehabilitation Research

SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY

Department of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

Assessing cognitive function after stroke. Glyn Humphreys

Service Related Project. Kimberley Keegan

PPMI Cognitive-Behavioral Working Group. Daniel Weintraub, MD

WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Cognitive and Psychiatric Characteristics of Huntington Disease. Rosa Ip, PhD, C. Psych, Jean Byers. MD., FRCPC, DABPN, Carol Harren, RN, CNC

Plenary Session 2 Psychometric Assessment. Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS

Mild Cognitive Impairment (MCI)

21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist

Stroke doubles the risk of dementia in epidemiological

Jung Wan Kim* Department of Speech Pathology of Daegu University, Gyeongsan, South Korea

Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History

Outline. Minority Issues in Aging Research. The Role of Research in the Clinical Setting. Why Participate in Research

NEUROPSYCHOLOGICAL ASSESSMENT

Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients

EMPIRICAL ISSUES IN THE STUDY OF COGNITIVE AGING THROUGH POPULATION-BASED STUDIES

Missing Data Analysis in Drug-Naïve Alzheimer s Disease with Behavioral and Psychological Symptoms

POST STROKE DEMENTIA: DIAGNOSIS & INTERVENTION. Danielle E. Eagan, Ph.D. Barrow Neurological Institute Stroke Symposium October 13, 2018

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

Neuropsychological Performance in Cannabis Users and Non-Users Following Motivation Manipulation

Monitoring/Screening Mood and Cognition in Patients after Stroke

Long-term cognitive impairment is a well-known consequence

Index. Addenbrooke s cognitive examination (ACE)

Research Article Rapid Screening for Cognitive Impairment in Parkinson s Disease: A Pilot Study

Erin Cullnan Research Assistant, University of Illinois at Chicago

Vaitsa Giannouli Bulgarian Academy of Sciences, Bulgaria Nikolaos Syrmos Aristotle University of Thessaloniki, Greece

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea

CommonKnowledge. Pacific University. Stefanie Fendrick Pacific University. Recommended Citation. Notice to Readers

Medial Temporal Atrophy and Memory Dysfunction in Poststroke Cognitive Impairment-No Dementia

AD Prevention Trials: An Industry Perspective

The neuropsychological profiles of mild Alzheimer s disease and questionable dementia as compared to age-related cognitive decline

TITLE: Endophenotypes of Dementia Associated with Traumatic Brain Injury in Retired Military Personnel

APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA

Sleep Problems Associated with Behavioral and Psychological Symptoms as Well as Cognitive Functions in Alzheimer s Disease

The Use of Brief Assessment Batteries in Multiple Sclerosis. History of Cognitive Studies in MS

Ingrid Susanne van Maurik

Effects of Comorbid Disease on Pre-treatment Neurobehavioral Functioning. Sunita K. Patel, PhD Assistant Professor. City of Hope Medical Center

MOS SF-36 health survey (Ware &

M P---- Ph.D. Clinical Psychologist / Neuropsychologist

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

Recent publications using the NACC Database. Lilah Besser

Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation

SOCIABLE DELIVERABLE D7.2a Interim Assessment of the SOCIABLE Platform and Services

Assessment of People with Early Dementia and their Families

David A Scott Lis Evered. Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne

Assessment for the Model Predicting of the Cognitive and Language Ability in the Mild Dementia by the Method of Data-Mining Technique

Department of Neurology, Hyoja Geriatric Hospital, Yongin, Korea. Department of Psychiatry, Yong-in Mental Hospital, Yongin, Korea

SCIENTIFIC DISCUSSION

The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV

Validation of ipad based treatment 1

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)

Post-Stroke Targeted Evaluation. Jon Van Doren, Ph.D. Arizona Neuropsychology, PC Scottsdale, AZ

Questionnaire information Name of the questionnaire Questionario per l'informatore [Informant questionnaire]

Post Stroke Cognitive Decline

AMNESTIC MINIMAL COGNITIVE IMPAIRMENT: BEYOND MEMORY

Blind moca assessment Address Submit

LOTCA Assessment review. Georgina Wrack. University of the Sunshine Coast

Progression of cognitive impairment in stroke patients

Clinical Study Depression Is Associated with Cognitive Dysfunction in Older Adults with Heart Failure

Supplementary Online Content

Comparison of Cognitive Function between Patients with Restless Legs Syndrome and Healthy Controls

T. Rune Nielsen, PhD

Speech perception in individuals with dementia of the Alzheimer s type (DAT) Mitchell S. Sommers Department of Psychology Washington University

Research Article Assessment of Early Cognitive Impairment in Patients with Clinically Isolated Syndromes and Multiple Sclerosis

Review Article Pediatric Multiple Sclerosis and Cognition: A Review of Clinical, Neuropsychologic, and Neuroradiologic Features

February 8, Prepared By: Glen M. Doniger, PhD Director of Scientific Development NeuroTrax Corporation

Supplementary online data

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?

Title: Robust Identification of Alzheimer s Disease subtypes based on cortical atrophy patterns

Hopkins Verbal Learning Test Revised: Norms for Elderly African Americans

INTRODUCTION. ORIGINAL ARTICLE Copyright 2016 Korean Neuropsychiatric Association

Melanie Fried-Oken, Ph.D., CCC/Sp Charity Rowland, Ph.D.

The Neuropsychology of

PRELIMINARY NORMS FOR YEAR OLDS ON THE MEMORY TEST FOR OLDER ADULTS (MTOA:S) ABSTRACT

Advisory Boards -- Dainippon Sumito Pharma; Takeda and Lundbeck. Off-label data included for Mirapex (pramipexole)

Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments

COGNITIVE AND BRAIN CHANGES IN MULTIPLE SCLEROSIS

Clinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly

Transcription:

Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP) Yeonwook Kang, Ph.D. Department of Psychology, Hallym University Department of Neurology, Hallym University Sacred Heart Hospital April 4, 2009

Outline Overview of the Korean VCI Harmonization Standardization (K-VCIHS) study The Korean VCI Neuropsychology Harmonization Construction of the Korean VCIHS neuropsychology tools Validation of the K-VCI neuropsychology protocol Reliability Validity Preliminary results of the K-VCIHS study

NINDS-Canadian Harmonization Workshop (2005) Stroke 2006;37:2220-2241

NINDS-Canadian Harmonization Workshop Foster multi-center collaboration and communication in the VCI community by coming up with a common core data set Working groups in epidemiology, imaging, neuropsychology, pathology, and experimental (animal) research Stroke 2006;37:2220-2241

Post-Stroke Cognitive Impairments: Prospective Multicenter Observational Study with Korean-Vascular Cognitive Impairment Harmonization Standardization Protocol

Aims of the Study To assess the incidence of newly developed Post-Stroke Dementia (PSD) & Post-Stroke Cognitive Impairment Not Dementia (PSCIND) in patients without pre-stroke dementia at 3 months after ischemic stroke To assess the prevalence of VD & VCIND at 3 months after ischemic stroke To assess the feasibility of K-VCIHS neuropsychological protocol To assess the risk factors of the cognitive impairments at 3 months after ischemic stroke To assess the relationships between the cognitive impairments at 3 months after ischemic stroke and other measures (MRDS, K-IADL, EuroQoL)

Methods Total number of patients: 500 (631) 13 centers over the country Seoul: 6 centers Gyeonggi-Do: 3 centers Busan: 2 centers Daejeon: 1 center Kwangju: 1 center Period: Oct. 1, 2007 ~ Dec. 31, 2008 PI: Dr. Byung-Chul Lee (Hallym University Sacred Heart Hospital) Seoul 6 centers Gyeonggi-Do 3 centers Daejeon 1 center Kwangju 1 center Busan 2 centers

Procedure V0 Enrollment V1 Acute phase evaluation within 14 days V2 Follow-up at 3 months Within 7 days after strokeonset 50% randomization* Informed consent Stroke onset Demographics Blood pressure Stroke risk factors profiles Medical history Concomitant medication Stroke subtypes Brain MRI / MRA ECG & Lab tests NIHSS MRDS (pre-stroke disability) Eligibility criteria K-VCIHS NP section - IQCODE (prestroke dementia) - 5-min K-VCIHS test NIHSS Neurological or medical complications Concomitant medication Vascular clinical outcome Concomitant medication K-VCIHS Neuropsy Test - IQCODE - K-MMSE - 60-min NP battery (30-min NP battery or 5-min NP test) -K-IADL BI, CDR, GDS MRDS, NIHSS, EuroQoL * Randomization: www.stroke-crc.or.kr 206/414 patients (as of Dec 31, 2008)

Culture provides specific models for thinking, acting, and feeling. Cognitive abilities measured by neuropsychological tests represent culturally learned abilities (Uzzell, 2007). The neuropsychological tests must be standardized in populations that are reasonably representative of the patients with whom you will use them. Although most Korean neuropsychological instruments were rooted in the neuropsychological tests originally developed in the United States, they were re-standardized for the Korean people.

NINDS Neuropsychology Protocols 60 Minute Protocol: When domain-specific information is needed for diagnosis of dementia or vascular CIND 30 Minute Protocol: A solid screening examination sensitive to VCI-related deficits 5 Minute Protocol: One that can be completed in a primary care physician s office or as part of a very large epidemiologic project. Also can potentially be administered by telephone

NINDS-CSN Neuropsychology Protocols Emphases in test selections Executive function Processing speed Memory Differentiation from Alzheimer s disease Cognitive domains Executive / Activation Language / Lexical retrieval Visuospatial Memory / Learning Neuropsychiatric / Depressive symptoms Premorbid Status

60-minute Protocol Cognitive Domain VCIHS Tests Korean VCIHS Tests Source Executive / Activation Animal Naming Animal Naming SNSB Phonemic Fluency (CFL, PRW) Phonemic Fluency ( ㄱ, ㅇ, ㅅ ) SNSB Digit Symbol Coding Digit Symbol Coding Korean WAIS Trail Making Test Korean TMT-elderly s version (K-TMT-e) Lee (2006) List Learning Test Strategies Seoul Verbal Learning Test SNSB-II Language BNT-Short form K-BNT: Short form A SNSB Visuospatial Rey: Copy Rey: Copy SNSB Memory Neuropsychiatric / Depressive Symptoms Others Hopkins Verbal Learning Test Seoul Verbal Learning Test SNSB California Verbal Learning Test (alternate) Korean-CVLT Kim & Kang (1999) NPI-Questionnaire version NPI-Q KAGP CES-D GDS, S-GDS SNSB-II IQCODE IQCODE-K Lee (2005) MMSE K-MMSE SNSB MoCA K-MoCA Kang (2009)

TMT: B K-TMT-e: B 1 Monday 2 Tuesday

Rey-Osterrieth Complex Figure

Normative data of the Korean-California Verbal Learning Test (K-CVLT, Kim & Kang, 1999) Subject: N=357 (M: 181, W: 176) Age: 20~79 yrs (49.5 ± 17.4) Men: 49.9±17.6 yrs Women: 49.1±17.2 yrs Norm for each variable Age: 5 categories (20~39, 40~49, 50~59, 60~69, 70~79) Sex

Montreal Cognitive Assessment (MoCA)

K-MoCA

5-min protocol (Subtests from the K- MoCA)

Validation of the K-VCIHS Neuropsychology Protocol (1) Reliability Test-retest reliability Healthy normal elderly N=30 (men: 14, women: 16) Age =71.57±6.40 yrs (range 64~96) Education =7.02±5.19 yrs (range 0~16) Test-retest interval = 27.59±2.06 days (range 24~31)

Table 1. Test-retest reliability of the K-VCIHS NP protocol Test 1st 2nd Intraclass Cor. Animal Naming 15.65 (5.00) 15.14 (4.13).64** Phonemic Fluency 21.14 (9.77) 24.71 (10.69).79*** Digit Symbol Coding 32.69 (13.97) 36.76 (15.92).86*** K-TMT-e: A 41.72 (24.62) 33.69 (16.21).66** K-TMT-e: B 69.04 (31.39) 72.59 (50.15).55** S-K-BNT 10.03 (2.67) 10.97 (2.71).75*** SVLT: Immediate recall 16.93 (4.64) 20.52 (4.43).35* SVLT: Delayed recall 4.93 (2.45) 6.66 (2.59).43** SVLT: Recognition 20.14 (2.17) 20.90 (1.80).45** Rey-Copy 28.69 (5.64) 29.29 (5.18).73*** GDS 10.03 (6.45) 9.24 (5.63).77** K-MMSE 25.59 (2.56) 26.00 (2.85).78*** * p<.05, **p<.01, ***p<.001

Validation of the K-VCIHS Neuropsychology Protocol (2) Validity Stroke patients* (n=56) Healthy normals (n=56) Age (yrs) 65.25 ± 13.74 65.54 ± 12.56 Sex (Men : Women) 28 : 28 28 : 28 Education (yrs) 9.20 ± 5.02 9.08 ± 5.15 * Assessed at the 3 months after ischemic stroke (Hallym University Sacred Heart Hospital; Jan 2008~Dec 2008)

Table 2. Test performances of the stroke patients and healthy normals Test Stroke patients (n=56) Healthy normals (n=56) Animal Naming 12.15 (5.38) 15.25 (4.51) 3.30** Phonemic Fluency 19.92 (12.31) 24.72 (12.27) 1.99* Digit Symbol Coding 38.12 (21.90) 44.27 (24.82) 1.34 K-TMT-e: A 51.53 (54.29) 29.82 (25.13) -2.67** K-TMT-e: B 80.57 (71.07) 57.29 (40.87) -1.98 S-K-BNT 9.91 (3.52) 11.77 (2.94) 3.03** SVLT: Immediate recall 16.48 (5.62) 18.95 (5.45) 2.36* SVLT: Delayed recall 4.21 (2.98) 6.45 (2.68) 4.17*** SVLT: Recognition 19.77 (2.65) 20.57 (2.45) 1.67 Rey-Copy 26.74 (9.62) 29.00 (8.09) 1.35 S-GDS (15) 6.45 (4.55) 3.20 (3.48) 4.25*** K-MMSE 24.61 (4.96) 27.05 (3.60) 2.99** * p<.05, **p<.01, ***p<.001 t

Preliminary results of the K-VCIHS study 5-min protocol (n=59) Scheduled patients for 3-month post-stroke assessment (n=414) 60-min protocol was not administered (n=75) [ neurological / medical conditions, aphasia, pt s refusal, etc.] Patients who completed the 60-min protocol (n=267) ADL missing (n=10) IQCODE missing (n=3) Normal (n=82, 30.7%) VCIND (n=133, 49.8%) VD (n=52, 19.5%)

Thank you for your attention!